Hypothesis' Enzyme Tech Targets Bacteria & Supports Balance
Laura McQuarrie — October 2, 2025 — Fashion
References: hypothesis.bio & cosmeticsbusiness
Hypothesis, the innovative skincare brand from Topaz Bioscience, has been awarded MyMicrobiome’s new Microbiome-Friendly Eczema certification for its products with breakthrough precision enzyme technology. Hypothesis' scientifically proven solutions reduce a specific bacteria found on skin—Staphylococcus aureus—with a patented enzyme called TPZ-01 that doesn't disrupt the rest of the skin's microbiome. "Dermatologists have long known the role of Staph aureus in eczema, but until now there haven't been tools designed to target it directly," said Oliver Liu, Ph.D, co-founder of Hypothesis and Topaz Biosciences, "Hypothesis fills this gap, and this independent certification from MyMicrobiome validates the innovation we bring to eczema care."
Hypothesis' microbiome-friendly skincare can be found in the two-piece Eczema Precision Kit, containing Eczema Precision Hydrogel and Eczema Therapy Cream.
Hypothesis' microbiome-friendly skincare can be found in the two-piece Eczema Precision Kit, containing Eczema Precision Hydrogel and Eczema Therapy Cream.
Trend Themes
-
Microbiome-centric Skincare — The rise of microbiome-centric skincare focuses on products that maintain and foster a healthy bacterial balance on the skin, emphasizing the need for innovations in targeted treatments like those developed by Hypothesis.
-
Precision Enzyme Technology — Advancements in precision enzyme technology provide targeted solutions that address specific skin conditions, offering new pathways for skincare treatments that do not compromise the skin's natural microbial ecosystem.
-
Bacteria-targeted Treatments — Emerging treatments that specifically target pathogenic bacteria without affecting beneficial ones open up extensive possibilities for personalized skincare, particularly in managing conditions like eczema.
Industry Implications
-
Dermatology — Incorporating targeted microbiome approaches is revolutionizing dermatology, paving the way for interventions that address skin conditions in a microbiome-friendly manner.
-
Biotechnology — Biotechnology is advancing skin health through the development of enzymes that offer precise microbiome preservation while tackling dermatological issues.
-
Cosmeceuticals — The cosmeceuticals industry is integrating scientific advancements in bacterial management, creating new demand for products that cater to sensitive and condition-specific skin care needs.
6.1
Score
Popularity
Activity
Freshness
